Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

@article{Martin2011BelataceptAN,
  title={Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.},
  author={Spencer T. Martin and Eric M Tichy and Steven Gabardi},
  journal={Pharmacotherapy},
  year={2011},
  volume={31 4},
  pages={394-407}
}
In the past decade, the availability of new immunosuppressive maintenance therapies for use in solid organ transplantation has remained limited. Patients and clinicians have relied on immunosuppressive drugs that require a significant amount of therapeutic monitoring and are associated with a variety of adverse effects that affect both quality of life and allograft function. Belatacept is an investigational intravenous biologic agent for long-term use in renal transplant recipients. The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…